611 W. Union Street
Benson, AZ 85602
(520) 586-0800

Health Choice Integrated Care crisis Line
1-877-756-4090

NurseWise 24-Hour Crisis Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530



SEABHS
611 W. Union Street
Benson, AZ 85602
(520) 586-0800

NurseWise 24-Hr Crisis Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530


powered by centersite dot net

Getting Started
Here are some forms to get started. These can be printed and brought with you so that you can pre-fill out some known info ahead of time. More...


Cancer
Resources
Basic InformationLatest News
New Cancer Drug Shows Promise Against Wide Range of TumorsFirefighters May Face Higher Odds for Skin CancerMany With Early Breast Cancer Are Skipping ChemoWoman's Selfie of Skin Cancer Went Viral, Sparked AwarenessASH: Daratumumab Aids Newly Diagnosed Multiple MyelomaArtificial Intelligence Promising for CA, Retinopathy DiagnosesPediatric Oncologists Willing to Consider Medical MarijuanaGet Active, Beat Lymphoma?SABCS: 3D Mammography Could Help Rein in Screening CostsOvarian CA Screening Potentially Cost-Effective in the U.S.Just a Little Weight Loss May Cut Breast Cancer RiskFor Breast Cancer Patients, Less Time on Hormonal Meds?Acupuncture May Ease Pain Tied to Breast Cancer CareSABCS: Ribociclib Ups PFS in HR+ HER2− Advanced Breast CancerBirth Control Pill Tied to Slight Rise in Breast Cancer RiskDoctors' Personal Experience of Breast Cancer May Impact CareNew Breast Cancer Drug May Benefit Younger Women, TooLymph Node Density Predicts Thyroid Cancer OutcomesInsurance Ups the Odds of Beating CancerOral Microbiome Composition Linked to Esophageal Cancer RiskHealth Tip: Understanding Family Cancer SyndromeFDA Approves Biosimilar Ogivri for Breast, Stomach CancersDifferences in Cancer Survival by Type of Insurance>40% of Cancers, Cancer Deaths Due to Modifiable Risk FactorsFDA Approves 'Biosimilar' Drug Ogivri for Breast, Stomach CancersGum Disease Tied to Yet Another Deadly Illness5 Things You Should Know About Cervical CancerLess Frequent Biopsy May Be Option in Prostate Cancer CareSex, Race, Age Disparities in Survival for HPV-Linked Cancer6 Percent of Cancers Caused by Excess Weight, DiabetesHistory of Prior Cancer Common in Newly Diagnosed PatientsMemo to Doctors: Spit Out the Bad News1 in 4 U.S. Seniors With Cancer Has Had It BeforeStool-Based Protein Combos Can Improve CRC ScreeningNAFLD Linked to Increased Cancer Incidence RateCancer Survivors Can Develop PTSD, TooDrug Combo Doesn't Lengthen Glioblastoma SurvivalHealth Tip: Talking With Your Child's Cancer-Care TeamER- Breast CA Risk Up for African-Americans With T2DMHow to Do a Skin Cancer Body CheckStudy Untangles Disparity in Colon Cancer Survival RatesDiabetes May Be Driving High Rates of Breast Cancer in Black WomenOral Chemotherapy Parity Laws Offer Some Financial ProtectionHealth Tip: Recognize Symptoms of Oral CancerBreast Cancer Recurrences Steady After Therapy CessationLow-Fat Diet May Cut Pancreatic Cancer Risk for Overweight Older WomenKnow the Signs of Ovarian Cancer and Your RisksHealth Tip: Accept Help if Your Child Has CancerAverage Cost of Care in Year After Ovarian Cancer Surgery ~$100KRisk of Breast Cancer's Return Can Linger for Decades
LinksBook ReviewsSelf-Help Groups
Related Topics

Medical Disorders
Pain Management

Counseling Visit Helps Patients Decide About Lung CA Screening


HealthDay News
Updated: Mar 20th 2017

new article illustration

MONDAY, March 20, 2017 (HealthDay News) -- A centralized counseling and shared decision-making visit correlates with improvement in patient knowledge about eligibility criteria, benefits, and harms of low-dose computed tomography (LDCT) lung cancer screening, according to a study published in the March issue of CHEST.

Peter J. Mazzone, M.D., M.P.H., from the Cleveland Clinic, and colleagues developed a centralized counseling and shared decision-making visit for a lung cancer screening program, which included confirmation of eligibility for screening, education, individualized risk assessment, time for questions, and data collection. Patients were surveyed before, immediately after, and at one month after the visit.

The researchers found that 5.4 percent of the 423 patients who had a visit did not proceed to CT screening. Overall, 125, 122, and 113 patients completed the initial, post-visit, and follow-up surveys, respectively. Patients had a poor level of understanding about the age and smoking eligibility criteria before the visit (8.8 and 13.6 percent correct, respectively) and about the benefits and harms of screening (55.2 and 38.4 percent correct, respectively). After the visit there was a significant improvement in knowledge for all questions (P = 0.03 to P < 0.0001). By the one-month follow-up, knowledge had waned, but it remained higher than before the visit.

"A centralized counseling and shared decision-making visit impacts the patient's knowledge about the eligibility criteria, benefits, and harms of lung cancer screening with LDCT, helping patients make value-based decisions," the authors write.

Abstract/Full Text (subscription or payment may be required)